Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000932799-08-000113
Filing Date
2008-05-13
Accepted
2008-05-13 17:05:20
Documents
1
Period of Report
2008-05-12

Document Format Files

Seq Description Document Type Size
1 davit4_ex.html 4  
1 davit4_ex.xml 4 5549
  Complete submission text file 0000932799-08-000113.txt   7657
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DORSEY & WHITNEY LLP 250 PARK AVENUE NEW YORK NY 10177
Business Address 212 735 0784
Davit Paul Stephen (Reporting) CIK: 0001323791 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 08828399